Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis

Cancer Letters

Volumn 306, Issue 2, 2011, Pages 205-213

  Tiwari, Ashish K ^a   Crawford, Susan E ^a   Radosevich, Andrew ^b   Wali, Ramesh K ^a   Stypula, Yolanda ^b   Kunte, Dhananjay P ^a   Mutyal, Nikhil ^b   Ruderman, Sarah ^b   Gomes, Andrew ^b   Cornwell, Mona L ^a   Cruz, Mart De La ^a   Brasky, Jeffrey ^a   Gibson, Tina P ^a   Backman, Vadim ^b   Roy, Hemant K ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b Northwestern University   (United States)

Author keywords

Colon cancer; Colon carcinogenesis; Neo angiogenesis

Indexed keywords

AZOXYMETHANE; CD31 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN TYPE 8; CONNECTIVE TISSUE GROWTH FACTOR; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEMOGLOBIN; MATRIX PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE; PROTEINASE INHIBITOR; PROTHROMBIN; SODIUM CHLORIDE; SPHINGOSINE KINASE 1; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DENSITY; DISEASE MODEL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MICROARRAY ANALYSIS; MICROVESSEL DENSITY; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPECTROSCOPY; SUBMUCOSA;

ADENOMA; ANIMALS; AZOXYMETHANE; BLOTTING, WESTERN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; INTESTINAL MUCOSA; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 79955465279     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.03.008     Document Type: Article

References (41)

1. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
2. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
3. Chai H., Brown R.E. Field effect in cancer-an update. Ann. Clin. Lab. Sci. 2009, 39:331-337.
4. Steiling K., Ryan J., Brody J.S., Spira A. The field of tissue injury in the lung and airway. Cancer Prev. Res. (Phila.) 2008, 1:396-403.
5. Levine J.S., Ahnen D.J. Clinical practice. Adenomatous polyps of the colon. N. Engl. J. Med. 2006, 355:2551-2557.
6. Paun B.C., Kukuruga D., Jin Z., Mori Y., Cheng Y., Duncan M., Stass S.A., Montgomery E., Hutcheon D., Meltzer S.J. Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. Cancer 2010, 116:4495-4501.
7. Hao C.Y., Moore D.H., Chiu Y.S., Wong P., Bennington J.L., Smith A.P., Chen L.C., Lee N.M. Altered gene expression in normal colonic mucosa of individuals with polyps of the colon. Dis. Colon Rectum 2005, 48:2329-2335.
8. Polley A.C., Mulholland F., Pin C., Williams E.A., Bradburn D.M., Mills S.J., Mathers J.C., Johnson I.T. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006, 66:6553-6562.
9. Alberts D.S., Einspahr J.G., Krouse R.S., Prasad A., Ranger-Moore J., Hamilton P., Ismail A., Lance P., Goldschmid S., Hess L.M., Yozwiak M., Bartels H.G., Bartels P.H. Karyometry of the colonic mucosa. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2704-2716.
10. Ahnen D.J., Byers T. Proliferation happens. JAMA 1998, 280:1095-1096.
11. Anti M., Marra G., Armelao F., Percesepe A., Ficarelli R., Ricciuto G.M., Valenti A., Rapaccini G.L., De Vitis I., D'Agostino G. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993, 34:525-530.
12. Wang D., Pezo R.C., Corner G., Sison C., Lesser M.L., Shenoy S.M., Mariadason J.M., Singer R.H., Augenlicht L.H. Altered dynamics of intestinal cell maturation in Apc1638N/+ mice. Cancer Res. 2010, 70:5348-5357.
13. Wali R.K., Roy H.K., Kim Y.L., Liu Y., Koetsier J.L., Kunte D.P., Goldberg M.J., Turzhitsky V., Backman V. Increased microvascular blood content is an early event in colon carcinogenesis. Gut 2005, 54:654-660.
14. Roy H.K., Gomes A.J., Ruderman S., Bianchi L.K., Goldberg M.J., Stoyneva V., Rogers J.D., Turzhitsky V., Kim Y., Yen E., Jameel M., Bogojevic A., Backman V. Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidoscopy: gender-specific implications. Cancer Prev. Res. (Phila.) 2010, 3:844-851.
15. Roy H.K., Liu Y., Wali R.K., Kim Y.L., Kromine A.K., Goldberg M.J., Backman V. Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis. Gastroenterology 2004, 126:1071-1081.
16. Banerjee A., Quirke P. Experimental models of colorectal cancer. Dis. Colon Rectum 1998, 41:490-505.
17. Chen J., Huang X.F. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol. Ther. 2009, 8:1313-1317.
18. Kunte D.P., Wali R.K., Koetsier J.L., Roy H.K. Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase. Mol. Cancer Ther. 2008, 7:1797-1806.
19. Kim Y.L., Liu K., Wali R.K., Roy H.K., Goldberg M.J., Kromine A.K., Chen K., Backman V. Detection of the initial stages of colorectal carcinogenesis using polarization light scattering spectroscopy with multivariate statistical analysis. Lasers Surg. Med. 2003, 13:13.
20. Kim Y.L., Liu Y., Turzhitsky V.M., Roy H.K., Wali R.K., Backman V. Coherent backscattering spectroscopy. Opt. Lett. 2004, 29:1906-1908.
21. Kim Y.L., Liu Y., Wali R.K., Roy H.K., Backman V. Low-coherent backscattering spectroscopy for tissue characterization. Appl. Opt. 2005, 44:366-377.
22. Roy H.K., Kim Y.L., Liu Y., Wali R.K., Goldberg M.J., Turzhitsky V., Horwitz J., Backman V. Risk stratification of colon carcinogenesis through enhanced backscattering spectroscopy analysis of the uninvolved colonic mucosa. Clin. Cancer Res. 2006, 12:961-968.
23. Roy H.K., Turzhitsky V., Kim Y., Goldberg M.J., Watson P., Rogers J.D., Gomes A.J., Kromine A., Brand R.E., Jameel M., Bogovejic A., Pradhan P., Backman V. Association between rectal optical signatures and colonic neoplasia: potential applications for screening. Cancer Res. 2009, 69:4476-4483.
24. Roy H.K., Kunte D.P., Koetsier J.L., Hart J., Kim Y.L., Liu Y., Bissonnette M., Goldberg M., Backman V., Wali R.K. Chemoprevention of colon carcinogenesis by polyethylene glycol: suppression of epithelial proliferation via modulation of SNAIL/beta-catenin signaling. Mol. Cancer Ther. 2006, 5:2060-2069.
25. Rastinejad F., Polverini P.J., Bouck N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56:345-355.
26. Folkman J. Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp. Cell Res. 2006, 312:594-607.
27. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
28. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
29. Aotake T., Lu C.D., Chiba Y., Muraoka R., Tanigawa N. Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis. Clin. Cancer Res. 1999, 5:135-142.
30. Shpitz B., Gochberg S., Neufeld D., Grankin M., Buklan G., Klein E., Bernheim J. Angiogenic switch in earliest stages of human colonic tumorigenesis. Anticancer Res. 2003, 23:5153-5157.
31. Cho N.L., Redston M., Zauber A.G., Carothers A.M., Hornick J., Wilton A., Sontag S., Nishioka N., Giardiello F.M., Saltzman J.R., Gostout C., Eagle C.J., Hawk E.T., Bartagnolli M.M. Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev. Res. (Phila Pa) 2008, 1:21-31.
32. Chen L., Hao C., Chiu Y., Wong P., Melnick J., Brotman M., Moretto J., Mendes F., Smith A., Bennington J., Moore D., Lee N. Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients. Cancer Res. 2004, 64:3694-3700.
33. Nyberg P., Heikkila P., Sorsa T., Luostarinen J., Heljasvaara R., Stenman U.H., Pihlajaniemi T., Salo T. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J. Biol. Chem. 2003, 278:22404-22411.
34. Gerber P.A., Hippe A., Buhren B.A., Muller A., Homey B. Chemokines in tumor-associated angiogenesis. Biol. Chem. 2009, 390:1213-1223.
35. Strieter R.M., Polverini P.J., Arenberg D.A., Walz A., Opdenakker G., Van Damme J., Kunkel S.L. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukocyte Biol. 1995, 57:752-762.
36. Roy H.K., Wali R.K., Kim Y., Liu Y., Hart J., Kunte D.P., Koetsier J.L., Goldberg M.J., Backman V. Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Lett. 2007, 581:3857-3862.
37. Gomes A.J., Roy H.K., Turzhitsky V., Kim Y., Rogers J.D., Ruderman S., Stoyneva V., Goldberg M.J., Bianchi L.K., Yen E., Kromine A., Jameel M., Backman V. Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia. Clin. Cancer Res. 2009, 15:3110-3117.
38. Menakuru S.R., Brown N.J., Staton C.A., Reed M.W. Angiogenesis in pre-malignant conditions. Br. J. Cancer 2008, 99:1961-1966.
39. Albini A., Noonan D.M., Ferrari N. Molecular pathways for cancer angioprevention. Clin. Cancer Res. 2007, 13:4320-4325.
40. Nico B., Benagiano V., Mangieri D., Maruotti N., Vacca A., Ribatti D. Evaluation of microvascular density in tumors: pro and contra. Histol. Histopathol. 2008, 23:601-607.
41. Murphy K.J., Nielson K.R., Albertine K.H. Defining a molecularly normal colon. J. Histochem. Cytochem. 2001, 49:667-668.